Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.64359 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.61519 | 61 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.60728 | 60 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.72668 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.57503 | 60 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.61561 | 59 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.95741 | 65 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.81212 | 64 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.59811 | 60 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.61626 | 61 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.60046 | 60 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.60037 | 61 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.61386 | 60 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.61346 | 61 |